Abstract:Background Neurotrophic factors such as brain derived neurotrophic factor (BDNF) are synthesized in a variety of neural and non-neuronal cell types and regulate survival, proliferation and apoptosis. In addition, bone morphogenetic proteins (BMPs) inhibit the proliferation of pulmonary large carcinoma cells bone morphogenetic protein receptor, type IA (BMPR1A). Little is known about the expression of BDNF or BMPR1A in malignant gall bladder lesions. This study was to evaluate BDNF and BMPR1A expression and evaluate the clinicopathological significance in benign and malignant lesions of the gallbladder. Methods The BDNF and BMPR1A expression of gallbladder adenocarcinoma, peritumoral tissues, adenoma, polyp and chronic cholecystitis were Immunohistochemically determined. Results BDNF expression was significantly higher in gallbladder adenocarcinoma than in peritumoral tissues, adenoma, polyps and chronic cholecystitis samples. However, BMPR1A expression was significantly lower in gallbladder adenocarcinoma than in peritumoral tissues, adenomas, polyps and chronic cholecystitis tissues. The specimens with increased expression of BDNF in the benign lesions exhibited moderate- or severe-dysplasia of gallbladder epithelium. BDNF expression was significantly lower in well-differentiated adenocarcinomas with maximum tumor diameter <2 cm, no metastasis to lymph nodes, and no invasion of regional tissues compared to poorly-differentiated adenocarcinomas with maximal tumor diameter >2 cm, metastasis of lymph node, and invasiveness of regional tissues in gallbladder adenocarcinoma. BMPR1A expression were significantly higher in the well-differentiated adenocarcinoma with maximal tumor diameter <2 cm, no metastasis of lymph node, and no invasion of regional tissues compared to poorly-differentiated adenocarcinomas with maximal tumor diameter >2 cm, metastasis of lymph node, and invasiveness of regional tissues in gallbladder. Univariate Kaplan-Meier analysis indicated increased expression of BDNF or decreased expression of BMPR1A was associated with decreased disease specific survival (DSS) rates. Similarly, multivariate Cox regression analysis showed increased expression of BDNF or decreased expression of BMPR1A are independent predictors of poor DSS rates in gallbladder adenocarcinoma. Conclusions In gallbladder malignancies, the increased expression of BDNF and decreased expression of BMPR1A were associated with increased risk of metastasis, regional invasion and mortality. They might serve as novel indicators of gallbladder adenocarcinoma outcomes, which may prove valuable for the development of personalized therapeutic paradigms.

Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions

Regulation of BMP2K in AP2M1-mediated EGFR Internalization During the Development of Gallbladder Cancer

Expression of ABCG2, SFRP2, BRMS1 and HPA in Benign and Malignant Lesions of the Gallbladder and Their Clinicopathological Significances

BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis-related Biomarkers for Gallbladder Adenocarcinoma.

Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer

Identification of Cd146 Expression, Angiogenesis, and Lymphangiogenesis As Progression, Metastasis, and Poor-Prognosis Related Markers for Gallbladder Adenocarcinoma

Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder

Correlation of S1P1 and ERp29 Expression to Progression, Metastasis, and Poor Prognosis of Gallbladder Adenocarcinoma

BDNF is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and is Associated with Brain Metastasis

Study on Pathological Significance in the Expression of the Nerve Growth Factor (NCF) and Its Mrna in Benign and Malignant Lesions of Gallbladder.

Nectin-2 and DDX3 Are Biomarkers for Metastasis and Poor Prognosis of Squamous Cell/adenosquamous Carcinomas and Adenocarcinoma of Gallbladder.

Expression of MK-1 and RegⅣ and its clinicopathological significances in the benign and malignant lesions of gallbladder

Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma

Study on the expression of GSCs marker and it′s regulated factor in benign and malignant gallbladder lesions

Deregulated Bone Morphogenetic Proteins and Their Receptors Are Associated with Disease Progression of Gastric Cancer.

Expression of PDGF-BmRNA in 108 Cases with Gallbladder Adenocarcinoma and Its Significance

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer

Expression and clinical significance of brain-derived neurotrophic factor in gastric cancer

Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types

Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.

Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression of Gallbladder Adenocarcinoma.